We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Biomarkers Evaluated for Subconcussive Head Trauma

By LabMedica International staff writers
Posted on 12 Jun 2018
Print article
Image: The Simoa single molecule array HD-1 analyzer (Photo courtesy of Quanterix).
Image: The Simoa single molecule array HD-1 analyzer (Photo courtesy of Quanterix).
Repetitive subconcussive head trauma is a consequence of participation in contact sports and may be linked to neurodegenerative diseases. The degree of neurological injury caused by subconcussive head trauma is not easily detectible, and this injury does not induce readily identifiable clinical signs or symptoms.

The accumulation of subconcussive head impacts over the course of a football season has been linked to neurophysiological and neuropsychological changes in athletes, and the accumulation of subconcussive head impacts over a long career has been suggested as a cause of severe neurodegenerative diseases such as Alzheimer's disease and chronic traumatic encephalopathy (CTE).

Scientists at the Texas Christian University (Fort Worth, TX, USA) and their colleagues obtained blood samples from thirty-five National Collegiate Athletic Association (NCAA) football players on seven different days, beginning before fall camp commenced and ending three weeks after the competitive football season had finished. The investigators wanted to examine fluctuations in plasma concentrations of tau and serum concentrations of neurofilament light polypeptide (NF-L) over the course of the entire football season, during which the number and magnitude of head impacts varied.

After blood collection, subsequent centrifugation is done at 2000g for 20 minutes at 4 °C within 30 minutes after collection. Following centrifugation, samples were transferred to prelabeled polypropylene vials and stored at −80 °C until biomarker quantification. Plasma concentrations of tau (Simoa Tau 2.0 Kit) and serum concentrations of NF-L (Simoa Beta Kit) were measured using digital array technology on a Simoa Single Molecule Array HD-1 Analyzer, software version 1.5. The same lot of kits was used to assay both tau and NF-L. Athletes were grouped based on their starter status, because athletes identified as starters are known to sustain a greater number of impacts. Between-group differences and time-course differences were assessed.

The scientists found that nonstarters, plasma concentrations of tau decreased over the course of the season, with lower values observed in starters; this resulted in a lower area under the curve (AUC) (starters: 416.78 ± 129.17 pg/mL/day; nonstarters: 520.84 ± 163.19 pg/mL/day). Plasma concentrations of tau could not be used to discern between starters and nonstarters. In contrast, serum concentrations of NF-L increased throughout the season as head impacts accumulated, specifically in those athletes categorized as starters. The higher serum concentrations of NF-L observed in starters resulted in a larger AUC (starters: 1,605.03 ± 655.09 pg/mL/day; nonstarters: 1,067.29 ± 272.33 pg/mL/day).

The authors concluded that the different patterns observed in serum NF-L and plasma tau concentrations provide preliminary evidence for the use of blood biomarkers to detect the neurological injury associated with repetitive subconcussive head trauma.

Jonathan M. Oliver, PhD, an Assistant Professor and the lead author of the study, said, “Given recent findings indicating a potential link between repetitive subconcussive impacts and the development of CTE, efforts to determine the effect of subconcussive impacts throughout an athlete's career may prove useful, especially if those efforts are feasible and cost effective.” The study was published on May 29, 2018, in the Journal of Neurosurgery.

Related Links:
Texas Christian University

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Creatine Kinase-MB Assay
CK-MB Test
New
Ultra-Low Temperature Freezer
iUF118-GX

Print article

Channels

Molecular Diagnostics

view channel
Image: The breakthrough could result in a higher success rate using a simple oral swab test before IVF (Photo courtesy of Shutterstock)

POC Oral Swab Test to Increase Chances of Pregnancy in IVF

Approximately 15% of couples of reproductive age experience involuntary childlessness. A significant reason for this is the growing trend of delaying family planning, a global shift that is expected to... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.